BioSpace News Archive

BioMidwest

Co-Diagnostics, Inc. Provides Update on “ABC” Test for Influenza A, Influenza B, and COVID-19

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that its Logix Smart™ ABC Test is anticipated to be ready for launch to US CLIA laboratory customers the first week of October 2020.

September 24, 2020
·
3 min read
Drug Development

Amicus Therapeutics Receives European Medicines Agency PRIME Designation for CLN6 Batten Disease Gene TherapyAdditional Phase 1/2 Data to be Presented at the Child Neurology Society Annual Meeting in October

Amicus Therapeutics announced the European Medicines Agency has granted Priority Medicines designation to AT-GTX-501, the Company’s investigational gene therapy for children living with variant late infantile neuronal ceroid lipofuscinosis 6 disease, also known as CLN6 Batten disease.

September 24, 2020
·
6 min read
Policy

Mereo BioPharma Receives FDA Rare Pediatric Disease Designation for Setrusumab for the Treatment of Osteogenesis Imperfecta

Mereo BioPharma Group plc, “Mereo” or “the Company”, a clinical-stage biopharmaceutical company focused on oncology and rare diseases, announces that the U.S. Food and Drug Administration has granted Rare Pediatric Disease designation to setrusumab for the treatment of osteogenesis imperfecta.

September 24, 2020
·
6 min read
BioCapital

Foundation Fighting Blindness To Jointly Host Online Continuing Medical Education (CME, COPE) Webinar

The event will review best practices for care and management of patients with inherited retinal diseases such as retinitis pigmentosa, Usher syndrome, and Stargardt disease.

September 24, 2020
·
3 min read
Biotech Bay

Indivior Takes Strategic Alignment Actions

Indivior PLC announced that it is taking organizational and cost actions to better align its capabilities and resources with the Group’s strategic priorities.

September 24, 2020
·
17 min read
Allergy Immunotherapy Market: Increased Funding for R&D Activities to Fuel Market Growth

The global market for allergy immunotherapy was initially valued at US$1.37 bn back in the year 2016.

September 24, 2020
·
4 min read
Centrifugal Blood Pump Market: Competitive Analysis and Key Developments

Centrifugal blood pumps have been mainstreamed in routine cardiac surgeries for more than one decade now.

September 24, 2020
·
5 min read
Influenza Medication Market: Pharmacies Held Lead However Hospitals Likely to Show Lucrative Prospects

The global influenza medication market is primarily driven by annual epidemic outbreak in developed countries such as the U.S. and flu outbreaks in several regions across the globe.

September 24, 2020
·
7 min read
Lentiviral Vectors Market | Increased Prevalence of Chronic Diseases is Likely to Bolster Demand in the Market

Lentiviral vectors find utilization as a medium to make a delivery of foreign genetic material into a separate cell.

September 24, 2020
·
3 min read
Leukapheresis Devices Market | Key Players Strategies Analysis | BioIVT, Grifols, S.A, Fresenius SE & Co. KGaA, STEMCELL Technologies Inc.

The drive for leukapheresis devices market stems from the need for improving therapeutic leukapheresis for the management of hyperleukocytosis and/or leukostasis.

September 24, 2020
·
3 min read